Skip to main content

Advertisement

Log in

The ALPPS Approach for the Management of Colorectal Carcinoma Liver Metastases

  • Colorectal Cancer Hepatic Metastases (KK Tanabe, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

Liver resection is the treatment of choice for patients with colorectal liver metastases (CRLM). The possibility of achieving curative resection is limited by the future liver remnant (FLR), with posthepatectomy liver failure (PHLF) the most severe possible complication after major liver resection. Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) has recently been introduced as a strategy for prevention of PHLF by inducing a rapid and large FLR hypertrophy not achieved by other methods. To date, most of the evidence regarding ALPPS is based on retrospective analysis of small series of patients or of case reports. The promising short-term results obtained are difficult to interpret oncologically, because of the heterogeneous groups of patients with different underlying pathology, variable chemotherapy use, and technical variations applied. Only increased experience and long-term outcomes will better define the utility of this novel method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  PubMed  CAS  Google Scholar 

  2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.

    Article  PubMed  Google Scholar 

  3. Rocha FG, Helton WS. Resectability of colorectal liver metastases: an evolving definition. HPB (Oxford). 2012;14(5):283–4.

    Article  Google Scholar 

  4. Adair RA, Young AL, Cockbain AJ, et al. Repeat hepatic resection for colorectal liver metastases. Br J Surg. 2012;99(9):1278–83.

    Article  PubMed  CAS  Google Scholar 

  5. Tzeng CW, Aloia TA. Colorectal liver metastases. J Gastrointest Surg. 2012 Oct 3. [Epub ahead of print].

  6. Robinson SM, Wilson CH, Burt AD, Manas DM, White SA. Chemotherapy—associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol. 2012 Jul 6. [Epub ahead of print].

  7. Mohammad WM, Martel G, Mimeault R, et al. Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons. HPB (Oxford). 2012;14(5):291–7.

    Article  Google Scholar 

  8. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg. 2012;255(2):237–47.

    Article  PubMed  Google Scholar 

  9. Viganò L, Ferrero A, Lo Tesoriere R, Capussotti L. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol. 2008;15(9):2458–64.

    Article  PubMed  Google Scholar 

  10. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.

    Article  PubMed  Google Scholar 

  11. Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg. 2009;197:686–90.

    Article  PubMed  Google Scholar 

  12. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–6.

    Article  PubMed  CAS  Google Scholar 

  13. Clavien PA, Petrowsky H, De Oliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545–1559-8.

    Article  PubMed  Google Scholar 

  14. Wicherts DA, Miller R, de Haas RJ, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248(6):994–1005.

    Article  PubMed  Google Scholar 

  15. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57.

    Article  PubMed  Google Scholar 

  16. Mueller L, Hillert C, Möller L, et al. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008;15(7):1908–17.

    Article  PubMed  CAS  Google Scholar 

  17. Simoneau E, Aljiffry M, Salman A, et al. Portal vein embolization stimulates tumor growth in patients with colorectal cancer liver metastases. HPB (Oxford). 2012;14(7):461–8.

    Article  Google Scholar 

  18. • Hoekstra LT, van Lienden KP, Doets A, et al. Tumor progression after preoperative portal vein embolization. Ann Surg. 2012;256(5):812–8. This is the first study to compare patients with and without portal vein embolization for whom tumor growth before and after embolization was reported.

    Article  PubMed  Google Scholar 

  19. •• Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling two-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14. The authors publish the largest series to date, covering the ALPPS approach in a multicenter study including 25 patients.

    Article  PubMed  Google Scholar 

  20. de Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg. 2012;255(3):415–7.

    Article  PubMed  Google Scholar 

  21. Baumgart J, Lang S, Lang H. A new method for induction of liver hypertrophy prior to right trisectionectomy: a report of three cases. HPB (Oxford). 2011;13 suppl 2:1–145.

    Google Scholar 

  22. • de Santibañes E, Alvarez FA, Ardiles V. How to avoid postoperative liver failure: a novel method. World J Surg. 2012;36:125–8. For the first time the function of both hemilivers during the interval period of ALPPS is evaluated by scintigraphy and the concept of an auxiliary liver is introduced.

    Article  PubMed  Google Scholar 

  23. Alvarez FA, Iniesta J, Lastiri J, et al. New method of hepatic regeneration. Cir Esp. 2011;89:645–9.

    Article  PubMed  Google Scholar 

  24. Sala S, Ardiles V, Ulla M, et al. Our initial experience with ALPPS technique: encouraging results. Updates Surg. 2012;64(3):167–72.

    Article  PubMed  Google Scholar 

  25. Donati M, Stavrou GA, Basile F, et al. Combination of in situ split and portal ligation: lights and shadows of a new surgical procedure. Ann Surg. 2012;256(3):e11–2. author reply e16–9.

    Article  PubMed  Google Scholar 

  26. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237(5):686–91.

    PubMed  Google Scholar 

  27. Clavien PA, Lillemoe KD. Note from the editors on the ALPPS e-Letters-to-the-Editor. Ann Surg. 2012;256(3):552.

    Article  PubMed  Google Scholar 

  28. • Alvarez FA, Ardiles V, Sanchez Claria R, Pekolj J, de Santibañes E. Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2012 Nov 27. [Epub ahead of print]. This technical report is based on the largest ALPPS experience in a single center without mortality.

  29. Ulla M, Ardiles V, Levy-Yeyati E, et al. New surgical strategy to induce liver hypertrophy: role of MDCT-volumetry to monitor and predict liver growth. Hepatogastroenterology. 2012;20:60(122).

    Google Scholar 

  30. Li J, Girotti P, Königsrainer I, Ladurner R, Königsrainer A, Nadalin S. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure?. J Gastrointest Surg. 2013 Jan 4. [Epub ahead of print].

  31. Dokmak S, Belghiti J. Which limits to the “ALPPS” approach? Ann Surg. 2012;256(3):e6. author reply e16–7.

    Article  PubMed  Google Scholar 

  32. Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253:656–65.

    Article  PubMed  Google Scholar 

  33. Moszkowicz D, Cauchy F, Dokmak S, Belghiti J. Routine pedicular lymphadenectomy for colorectal liver metastases. J Am Coll Surg. 2012;214(6):e39–45.

    Article  PubMed  Google Scholar 

  34. Jaeck D, Nakano H, Bachellier P, et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol. 2002;9(5):430–8.

    Article  PubMed  Google Scholar 

  35. Aloia TA, Vauthey JN. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg. 2012;256(3):e9. author reply e16–9.

    Article  PubMed  Google Scholar 

  36. Jain HA, Bharathy KG, Negi SS. Associating liver partition and portal vein ligation for staged hepatectomy: will the morbidity of an additional surgery be outweighed by better patient outcomes in the long-term? Ann Surg. 2012;256(3):e10. author reply e16–7.

    Article  PubMed  Google Scholar 

  37. Narita M, Oussoultzoglou E, Ikai I, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;256(3):e7–8. author reply e16–7.

    Article  PubMed  Google Scholar 

  38. Govil S. Rapid improvement in liver volume induced by portal vein ligation and staged hepatectomy: the ALPPS procedure. HPB (Oxford). 2012;14(12):874.

    Article  Google Scholar 

  39. Strobel O, Büchler MW. Portal vein ligation combined with in situ splitting. Rapid hypertrophy of the liver remnant enables 2-stage extended hepatic resections. Chirurg. 2012;83(5):483.

    Article  PubMed  CAS  Google Scholar 

  40. Loos M, Friess H. Is there new hope for patients with marginally resectable liver malignancies. World J Gastrointest Surg. 2012;4(7):163–5.

    Article  PubMed  Google Scholar 

  41. Schnitzbauer AA, Lang SA. ALPPS: response to letter to the editor. Ann Surg. 2012;256(3):e16–7.

    Article  Google Scholar 

  42. Clavien PA. de Santibañes. The ALPPS: time to explore! Ann Surg. 2012;256(3):e18–9.

    Article  Google Scholar 

  43. • Andriani OC. Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg. 2012;256(3):e5. author reply e16–9. The longest survivals with ALPPS are reported in this interesting letter to the editor.

    Article  PubMed  Google Scholar 

  44. Machado MA, Makdissi FF, Surjan RC. Totally laparoscopic ALPPS is feasible and may be worthwhile. Ann Surg. 2012;256(3):e13. author reply e16–9.

    Article  PubMed  Google Scholar 

  45. Conrad C, Shivathirthan N, Camerlo A, Strauss C, Gayet B. Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg. 2012;256(3):e14–5. author reply e16–7.

    Article  PubMed  Google Scholar 

  46. Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol. 2011;26 Suppl 1:203–12.

    Article  PubMed  Google Scholar 

  47. Ding BS, Nolan DJ, Butler JM, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310–5.

    Article  PubMed  CAS  Google Scholar 

  48. Abshagen K, Eipel C, Vollmar B. A critical appraisal of the hemodynamic signal driving liver regeneration. Langenbecks Arch Surg. 2012;397(4):579–90.

    Article  PubMed  Google Scholar 

  49. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010;176(1):2–13.

    Article  PubMed  CAS  Google Scholar 

  50. Nadalin S, Testa G, Malagó M, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl. 2004;10(8):1024–9.

    Article  PubMed  Google Scholar 

  51. Zappa M, Dondero F, Sibert A, et al. Liver regeneration at day 7 after right hepatectomy: global and segmental volumetric analysis by using CT. Radiology. 2009;252(2):426–32.

    PubMed  Google Scholar 

  52. Madoff DC, Abdalla EK, Gupta S, et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005;16:215–25.

    Article  PubMed  Google Scholar 

  53. Goéré D, Farges O, Leporrier J, et al. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg. 2006;10(3):365–70.

    Article  PubMed  Google Scholar 

  54. Sturesson C, Keussen I, Tranberg KG. Prolonged chemotherapy impairs liver regeneration after portal vein occlusion—an audit of 26 patients. Eur J Surg Oncol. 2010;36(4):358–64.

    Article  PubMed  CAS  Google Scholar 

  55. Narita M, Oussoultzoglou E, Chenard MP, et al. Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization. Surg Today. 2011;41(1):7–17.

    Article  PubMed  Google Scholar 

  56. Millet G, Truant S, Leteurtre E, et al. Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients. Ann Surg. 2012;256(5):755–61.

    Article  PubMed  Google Scholar 

  57. Cavaness KM, Doyle MB, Lin Y, et al. Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis. J Gastrointest Surg. 2013;17(1):207–12.

    Google Scholar 

  58. Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2010;17(11):2870–6.

    Article  PubMed  Google Scholar 

  59. Scatton O, Belghiti J, Dondero F, et al. Harvesting the middle hepatic vein with a right hepatectomy does not increase the risk for the donor. Liver Transpl. 2004;10(1):71–6.

    Article  PubMed  Google Scholar 

  60. • de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg. 2011;98(6):825–34. The authors demonstrated that after portal vein embolization, future liver remnant function is recovered before volume.

    Article  PubMed  Google Scholar 

  61. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg. 1996;223(1):77–83.

    Article  PubMed  CAS  Google Scholar 

  62. Stockmann M, Lock JF, Malinowski M, et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford). 2010;12(2):139–46.

    Article  Google Scholar 

  63. de Graaf W, van Lienden KP, van Gulik TM, Bennink RJ. (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med. 2010;51(2):229–36.

    Article  PubMed  Google Scholar 

  64. de Graaf W, van Lienden KP, Dinant S, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg. 2010;14(2):369–78.

    Article  PubMed  Google Scholar 

  65. Oldhafer KJ, Donati M, Maghsoudi T, Ojdanić D, Stavrou GA. Integration of 3D volumetry, portal vein transection and in situ split procedure: a new surgical strategy for inoperable liver metastasis. J Gastrointest Surg. 2012;16(2):415–6.

    Article  PubMed  Google Scholar 

  66. Cauchy F, Aussilhou B, Dokmak S, et al. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg. 2012;256(5):746–54.

    Article  PubMed  Google Scholar 

  67. Wicherts DA, de Haas RJ, Andreani P, et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg. 2010;97(2):240–50.

    Article  PubMed  CAS  Google Scholar 

  68. de Santibañes E, Fernandez D, Vaccaro C, et al. Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases. World J Surg. 2010;34(9):2133–40.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Fernando A. Alvarez declares that he has no conflict of interest. Victoria Ardiles declares that she has no conflict of interest. Eduardo de Santibañes declares that he has no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo de Santibañes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alvarez, F.A., Ardiles, V. & de Santibañes, E. The ALPPS Approach for the Management of Colorectal Carcinoma Liver Metastases. Curr Colorectal Cancer Rep 9, 168–177 (2013). https://doi.org/10.1007/s11888-013-0159-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-013-0159-4

Keywords

Navigation